Log In
BCIQ
Print this Print this
 

GA-map IBS Dysbiosis Test

  Manage Alerts
Collapse Summary General Information
Company Genetic Analysis A/S
DescriptionTest that utilizes common and variable DNA sequences within the bacterial 16S rRNA gene to characterize and identify bacteria
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGastrointestinal, Diagnostic
Indication DetailsAnalyze dysbiosis (imbalances in gut microbiota) in patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/05/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today